Viewing Study NCT01853618

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 4:51 AM
Ignite Modification Date: 2026-05-12 @ 10:48 AM
Study NCT ID: NCT01853618
Status: COMPLETED
Last Update Posted: 2019-12-10
First Post: 2013-05-02
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: Tremelimumab With Chemoembolization or Ablation for Liver Cancer
Sponsor: National Cancer Institute (NCI)
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heptocellular Cancer View
None Biliary Tract Neoplasms View
None Liver Cancer View
None Hepatocellular Carcinoma View
None Biliary Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Blocking of Immune Suppression View
None Monoclonal Antibody View
None Immunotherapy View
None Ablative Therapy View